(VIANEWS) – NASDAQ Composite ended the session with Arcturus Therapeutics (ARCT) rising 2.2% to $32.95 on Wednesday while NASDAQ Composite jumped 0.92% to $14,631.95.


Today’s last reported volume for Arcturus Therapeutics is 350482, 33.57% below its average volume of 527561.

Arcturus Therapeutics’s last close was $32.24, 75.14% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is a negative 34.5% for the ongoing quarter and 321.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 289.1% and a negative 129.3%, respectively.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 9.54M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $32.95 at 17:17 EST, way below its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is higher than its 50-day moving average of $32.64 and way under its 200-day moving average of $45.09.

More news about Arcturus Therapeutics (ARCT).


Please enter your comment!
Please enter your name here